168 related articles for article (PubMed ID: 2448095)
21. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R
Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126
[TBL] [Abstract][Full Text] [Related]
22. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
23. A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma.
Omran MM; Farid K; Omar MA; Emran TM; El-Taweel FM; Tabll AA
Ann Hepatol; 2020; 19(2):179-185. PubMed ID: 31648804
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
[TBL] [Abstract][Full Text] [Related]
25. Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.
Maringhini A; Cottone M; Sciarrino E; Marcenò MP; La Seta F; Rinaldi F; Pagliaro L
Cancer; 1984 Dec; 54(12):2924-6. PubMed ID: 6208995
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis.
Iavarone M; Lampertico P; Ronchi G; Del Ninno E; Zanella A; Colombo M
J Viral Hepat; 2003 Nov; 10(6):423-6. PubMed ID: 14633174
[TBL] [Abstract][Full Text] [Related]
27. Liver Stiffness and Serum Alpha-Fetoprotein in Discriminating Small Hepatocellular Carcinoma from Cirrhotic Nodule.
Li JW; Ling WW; Lu Q; Lu CL; He D; Luo Y
Ultrasound Q; 2016 Dec; 32(4):319-326. PubMed ID: 27575844
[TBL] [Abstract][Full Text] [Related]
28. Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.
Tremolda F; Benevegnù L; Drago C; Casarin C; Cechetto A; Realdi G; Ruol A
Hepatogastroenterology; 1989 Dec; 36(6):519-21. PubMed ID: 2482242
[TBL] [Abstract][Full Text] [Related]
29. Detection of hepatocellular carcinoma-specific alpha-fetoprotein by isoelectric focusing.
Burditt LJ; Johnson MM; Johnson PJ; Williams R
Cancer; 1994 Jul; 74(1):25-9. PubMed ID: 7516264
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
31. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
33. Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.
Cottone M; Turri M; Caltagirone M; Maringhini A; Sciarrino E; Virdone R; Fusco G; Orlando A; Marino L; Pagliaro L
Hepatogastroenterology; 1988 Jun; 35(3):101-3. PubMed ID: 2456973
[TBL] [Abstract][Full Text] [Related]
34. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
Kim Y; Park YH; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Lee SG
Ann Transplant; 2016 Oct; 21():660-667. PubMed ID: 27777395
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.
Saitoh S; Ikeda K; Koida I; Suzuki Y; Kobayashi M; Tsubota A; Arase Y; Chayama K; Murashima N; Kumada H
Cancer; 1995 Oct; 76(7):1139-44. PubMed ID: 8630889
[TBL] [Abstract][Full Text] [Related]
37. A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.
Ertle JM; Heider D; Wichert M; Keller B; Kueper R; Hilgard P; Gerken G; Schlaak JF
Digestion; 2013; 87(2):121-31. PubMed ID: 23406785
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.
Singal AG; Conjeevaram HS; Volk ML; Fu S; Fontana RJ; Askari F; Su GL; Lok AS; Marrero JA
Cancer Epidemiol Biomarkers Prev; 2012 May; 21(5):793-9. PubMed ID: 22374994
[TBL] [Abstract][Full Text] [Related]
39. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
[TBL] [Abstract][Full Text] [Related]
40. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
